Related Experiment Video
Updated: May 3, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Myocardial infarction type 4b in human immunodeficiency virus-infected patient
Aneta Cybula-Walczak1, Filip M Szymanski2, Anna E Platek2
1Department of Hepatology and Acquired Immunodeficiencies, Medical University of Warsaw, Warsaw, Poland.
Abstract:
We report a case of a 52-year-old human immunodeficiency virus (HIV)-infected male patient receiving combined antiretroviral therapy (cART), who presented with acute ST-elevation myocardial infarction (STEMI). He was properly treated (e.g., prescribed anti-coagulation drugs: aspirin, clopidogrel, enoxaparin) and discharged. After 1.5 months, another STEMI related with in-stent thrombosis took place. The cART scheme was altered, resulting in no further cardiac events in the follow-up period, with undetectable levels of HIV ribonucleic acid. This case highlights the association between HIV infection and the specific drugs of cART, and the risk of cardiovascular disease development.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Endocarditis IV: Nursing Management
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction

